Search Results - "Fuentes, S Ruíz"

CP-200 Reactivation of hepatitis B after antineoplastic or immunosuppressive therapy by Fernández, C García, Peña, C Gómez, Romero, R Morón, Hidalgo, I Casas, Medina, MDC González, Corpás, M Valle, Rustarazo, S Belda, Fuentes, S Ruíz

“…BackgroundAdministration of immunosuppressive drugs can cause reactivation of hepatitis B virus (HBV), both asymptomatic and fulminant hepatitis. In July 2014,…”
Get full text

5PSQ-016 Safe use of antiplatelet medication: approaching the optimal dose of aspirin by pharmaceutical intervention by López-Álvarez, C, Ruiz-Fuentes, S, Domínguez-Recio, A, Blanco-Bermejo, C

“…BackgroundBased on available evidence and its benefit/risk balance, acetylsalicylic acid (ASA) is the first-line antiplatelet drug of choice for secondary…”
Get full text

2SPD-013 Economic impact of biosimilar infliximab use by García-Fernandez, C, Ruiz-Fuentes, S, Belda-Rustarazo, S, Gómez-Peña, C, Morón-Romero, R, Gómez-Nieto, P

“…BackgroundThe prescriptions of biologics are increasing as new indications and drugs are authorised. Since biosimilar drugs were introduced in the…”
Get full text